Difference between revisions of "Paul McKay"

From QueerBio.com
Jump to: navigation, search
 
Line 15: Line 15:
  
 
Senior researcher working on the mucosal vaccinology team in the Department of Medicine, Imperial College London.  Team member who developed the COVID-19 vaccine in 2020/2021.  His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue.
 
Senior researcher working on the mucosal vaccinology team in the Department of Medicine, Imperial College London.  Team member who developed the COVID-19 vaccine in 2020/2021.  His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue.
 +
 +
==See Also==
 +
 +
* [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]]
  
 
==Further Reading/Research==
 
==Further Reading/Research==

Latest revision as of 20:41, 19 September 2021

Paul McKay

Country

Great Britain

Birth - Death

Occupation

Scientist

Description

Senior researcher working on the mucosal vaccinology team in the Department of Medicine, Imperial College London. Team member who developed the COVID-19 vaccine in 2020/2021. His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue.

See Also

Further Reading/Research


Share on Facebook